+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Liquid Biopsy Market Report: Trends, Forecast and Competitive Analysis

  • ID: 5393406
  • Report
  • July 2021
  • Region: Global
  • 264 pages
  • Lucintel
UP TO OFF
until Dec 31st 2021

FEATURED COMPANIES

  • Biocept, Inc.
  • Bio-Rad Laboratories
  • Cardiff Oncology
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health
  • Illumina, Inc.
The future of the global liquid biopsy market looks promising with opportunities in reference laboratories, hospitals and physician laboratories, and academic and research centers. The global liquid biopsy market is expected to reach an estimated $9.3 billion by 2026 with a CAGR of 17% from 2020 to 2026. The major drivers for this market are the increasing prevalence of cancer, preference for non-invasive procedures and increasing need of early detection of high precision diseases in real time.

Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector.

A total of 163 figures/charts and 129 tables are provided in this 264-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global Liquid Biopsy market report, then read this report.

The study includes trends and forecasts for the global liquid biopsy market by product, circulating biomarker, application, clinical application, end user, and region as follows:

By Product [Value ($M) from 2015 to 2026]:
  • Assays Kits
  • Instruments
  • Services
By Circulating Biomarker [Value ($M) from 2015 to 2026]:
  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (CtDNA)
  • Cell-Free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Other Biomarkers
By Application [Value ($ Million) from 2015 to 2026]:
  • Oncology
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Other Cancers
  • Non-Cancer
By Clinical Application [Value ($ Million) from 2015 to 2026]:
  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring
By End User [Value ($ Million) from 2015 to 2026]:
  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Academic and Research Centers
  • Other End Users
By Region [Value ($ Million) from 2015 to 2026]:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • ROW
  • Brazil
Some of the liquid biopsy companies profiled in this report Guardant, Bio-Rad Laboratories, Qaigen, MDxHealth, Myraid, Biocept, Roche, Illumina, and Thermofisher.

The analyst circulating tumor DNA will remain the largest segment and is also expected to witness the highest growth over the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting disease in real time and in early stage.

Therapy selection will remain the largest clinical application over the forecast period due to its offerings of various benefits such as non-invasiveness, access to tumor heterogeneity, real-time treatment monitoring, and recurrence detection in advance of significant tumor formation or metastasis.

APAC will remain the fastest growing region over the forecast period due to rising non-invasive treatment, a rising incidence of cancer, and improving healthcare infrastructure.

Features of the Global Liquid Biopsy Market
  • Market Size Estimates: Global liquid biopsy market size estimation in terms of value ($B) and volume (Million Metric Ton) shipment.
  • Trend and Forecast Analysis: Market trends (2015-2020) and forecast (2021-2026) by various segments.
  • Segmentation Analysis: Global liquid biopsy market size by product, circulating biomarker, application, clinical application, end user, and region in terms of value.
  • Regional Analysis: Global liquid biopsy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different by product, circulating biomarker, application, clinical application, end user, and region for the global liquid biopsy market.
  • Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the global Liquid Biopsy market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions

Q.1 What are some of the most promising growth opportunities for the global liquid biopsy market by product (assay kits, instruments, and services), circulating biomarker (circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other biomarkers), application (oncology and non-cancer liquid biopsies), clinical application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring) end user (reference laboratories, hospitals and physician laboratories, academic and research centers, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global Liquid Biopsy market?
Q.5 What are the business risks and threats to the global liquid biopsy market?
Q.6 What are the emerging trends in this liquid biopsy market and the reasons behind them?
Q.7 What are some changing demands of customers in the liquid biopsy market?
Q.8 What are the new developments in the liquid biopsy market? Which companies are leading these developments?
Q.9 Who are the major players in the liquid biopsy market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the liquid biopsy market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global liquid biopsy market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocept, Inc.
  • Bio-Rad Laboratories
  • Cardiff Oncology
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health
  • Illumina, Inc.
1. Executive Summary

2. Global Liquid Biopsy Market Background and Classifications
2.1: Introduction, Background and Classification
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2015 to 2026
3.1: Macroeconomic Trends and Forecasts
3.2: Global Liquid Biopsy Market Trends and Forecast
3.3: Global Liquid Biopsy Market by Product
3.3.1: Assay Kits
3.3.2: Instruments
3.3.3: Services
3.4: Global Liquid Biopsy Market by Circulating Biomarker
3.4.1: Circulating Tumor Cells (CTCs)
3.4.2: Circulating Tumor DNA (ctDNA)
3.4.3: Cell-Free DNA (cfDNA)
3.4.4: Extracellular Vesicles (EVs)
3.4.5: Other Circulating Biomarkers
3.5: Global Liquid Biopsy Market by Application
3.5.1: Oncology
3.5.1.1: Lung Cancer
3.5.1.2: Breast Cancer
3.5.1.3: Colorectal Cancer
3.5.1.4: Prostate Cancer
3.5.1.5: Liver Cancer
3.5.1.6: Other Cancer
3.5.2: Non-Cancer
3.6: Global Liquid Biopsy Market by Clinical Application
3.6.1: Early Cancer Screening
3.6.2: Therapy Selection
3.6.3: Treatment Monitoring
3.6.4: Recurrence Monitoring
3.7: Global Liquid Biopsy Market by End User
3.7.1: Reference Laboratories
3.7.2: Hospitals and Physician Laboratories
3.7.3: Academic and Research Centers
3.7.4: Other End Users

4. Market Trends and Forecast Analysis from 2015 to 2026
4.1: Global Liquid Biopsy Market by Region
4.2: North American Liquid Biopsy Market Trends and Forecast
4.2.1: North American Liquid Biopsy Market by Product
4.2.2: North American Liquid Biopsy Market by Circulating Biomarker
4.2.3: North American Liquid Biopsy Market by Application
4.2.4: North American Liquid Biopsy Market by Clinical Application
4.2.5: North American Liquid Biopsy Market by End User
4.2.6: United States Liquid Biopsy Market
4.2.7: Canadian Liquid Biopsy Market
4.2.8: Mexican Liquid Biopsy Market
4.3: European Liquid Biopsy Market Trends and Forecast
4.3.1: European Liquid Biopsy Market by Product
4.3.2: European Liquid Biopsy Market by Circulating Biomarker
4.3.3: European Liquid Biopsy Market by Application
4.3.4: European Liquid Biopsy Market by Clinical Application
4.3.5: European Liquid Biopsy Market by End User
4.3.6: United Kingdom Liquid Biopsy Market
4.3.7: German Liquid Biopsy Market
4.3.8: French Liquid Biopsy Market
4.3.9: Italian Liquid Biopsy Market
4.3.10: Spanish Liquid Biopsy Market
4.4: APAC Liquid Biopsy Market Trends and Forecast
4.4.1: APAC Liquid Biopsy Market by Product
4.4.2: APAC Liquid Biopsy Market by Circulating Biomarker
4.4.3: APAC Liquid Biopsy Market by Application
4.4.4: APAC Liquid Biopsy Market by Clinical Application
4.4.5: APAC Liquid Biopsy Market by End User
4.4.6: Japanese Liquid Biopsy Market
4.4.7: Chinese Liquid Biopsy Market
4.4.8: Indian Liquid Biopsy Market
4.5: ROW Liquid Biopsy Market Trends and Forecast
4.5.1: ROW Liquid Biopsy Market by Product
4.5.2: ROW Liquid Biopsy Market by Circulating Biomarker
4.5.3: ROW Liquid Biopsy Market by Application
4.5.4: ROW Liquid Biopsy Market by Clinical Application
4.5.5: ROW Liquid Biopsy Market by End User
4.5.6: Brazilian Liquid Biopsy Market

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Liquid Biopsy Market by Product
6.1.2: Growth Opportunities for the Global Liquid Biopsy Market by Circulating Biomarker
6.1.3: Growth Opportunities for the Global Liquid Biopsy Market by Application
6.1.4: Growth Opportunities for the Global Liquid Biopsy Market by Clinical Application
6.1.5: Growth Opportunities for the Global Liquid Biopsy Market by End User
6.1.6: Growth Opportunities for the Global Liquid Biopsy Market by Region
6.2: Emerging Trends in the Global Liquid Biopsy Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Licensing and Certification
6.3.3: Mergers, Acquisitions, Joint Ventures, and Other Collaborations in the Global Liquid Biopsy Market

7. Company Profiles of Leading Players
7.1: Bio-Rad Laboratories
7.2: QIAGEN
7.3: MDxHealth
7.4: Myriad Genetics
7.5: Biocept, Inc.
7.6: F. Hoffmann-La Roche Ltd.
7.7: Thermo Fisher Scientific Inc.
7.8: Illumina, Inc.
7.9: Cardiff Oncology
7.10: Guardant Health

List of Figures
Chapter 2. Global Liquid Biopsy Market Background and Classifications
Figure 2.1: Classification of the Global Liquid Biopsy Market
Figure 2:2: Global Liquid Biopsy Market by Product
Figure 2:3: Assay Kits
Figure 2:4: Instruments
Figure 2.5: Services
Figure 2:6: Global Liquid Biopsy Market by Circulating Biomarker
Figure 2:7: Circulating Tumor Cells (CTCs)
Figure 2:8: Circulating Tumor DNA (ctDNA)
Figure 2:9: Cell-Free DNA (cfDNA)
Figure 2:10: Extracellular Vesicles (EVs)
Figure 2:11: Other Biomarkers
Figure 2:12: Global Liquid Biopsy Market by Application
Figure 2:13: Circulating Tumor Cells (CTCs)
Figure 2:14: Lung Cancer
Figure 2:15: Breast Cancer
Figure 2:16: Colorectal Cancer
Figure 2:17: Prostate Cancer
Figure 2:18: Liver Cancer
Figure 2:19: Other Cancers
Figure 2:20: Early Cancer Screening
Figure 2:21: Therapy Selection
Figure 2:22: Treatment Monitoring
Figure 2:23: Recurrence Monitoring
Figure 2:24: Reference Laboratories
Figure 2:25: Hospitals and Physician Laboratories
Figure 2:26: Academic and Research Centers
Figure 2:27: Other End Users
Figure 2.28: Major Drivers and Challenges for the Global Liquid Biopsy Market

Chapter 3. Market Trends and Forecast Analysis from 2015 to 2026
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Regional Per Capita Income Trends
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Global Unemployment Rate
Figure 3.15: Forecast for the Regional GDP Growth Rate
Figure 3.16: Forecast for the Regional Population Growth Rate
Figure 3.17: Forecast for the Regional Inflation Rate
Figure 3.18: Forecast for the Regional Unemployment Rate
Figure 3.19: Forecast for Regional Per Capita Income
Figure 3.20: Trends and Forecast for the Global Liquid Biopsy Market (2015-2026)
Figure 3.21: Trends of the Global Liquid Biopsy Market ($M) by Product (2015-2020)
Figure 3.22: Forecast for the Global Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 3.23: Trends and Forecast for Assay Kits in the Global Liquid Biopsy Market (2015-2026)
Figure 3.24: Trends and Forecast for Instruments in the Global Liquid Biopsy Market (2015-2026)
Figure 3.25: Trends and Forecast for Services in the Global Liquid Biopsy Market (2015-2026)
Figure 3.26: Trends of the Global Liquid Biopsy Market ($M) by Circulating Biomarker (2015-2020)
Figure 3.27: Forecast for the Global Liquid Biopsy Market ($M) by Circulating Biomarker (2021-2026)
Figure 3.28: Trends and Forecast for Circulating Tumor Cells (CTCs) in the Global Liquid Biopsy Market (2015-2026)
Figure 3.29: Trends and Forecast for Circulating Tumor DNA (ctDNA) in the Global Liquid Biopsy Market (2015-2026)
Figure 3.30: Trends and Forecast for Cell-Free DNA (cfDNA) in the Global Liquid Biopsy Market (2015-2026)
Figure 3.31: Trends and Forecast for Extracellular Vesicles (EVs) in the Global Liquid Biopsy Market (2015-2026)
Figure 3.32: Trends and Forecast for Other Circulating Biomarkers in the Global Liquid Biopsy Market (2015-2026)
Figure 3.33: Trends of the Global Liquid Biopsy Market ($M) by Application (2015-2020)
Figure 3.34: Forecast for the Global Liquid Biopsy Market ($M) by Application (2021-2026)
Figure 3.35: Trends and Forecast for Oncology in the Global Liquid Biopsy Market (2015-2026)
Figure 3.36: Trends of Oncology in the Global Liquid Biopsy Market ($M) by Type (2015-2020)
Figure 3.37: Forecast for Oncology in the Global Liquid Biopsy Market ($M) by Type (2021-2026)
Figure 3.38: Trends and Forecast for Lung Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.39: Trends and Forecast for Breast Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.40: Trends and Forecast for Colorectal Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.41: Trends and Forecast for Prostate Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.42: Trends and Forecast for Liver Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.43: Trends and Forecast for Other Cancers in the Global Liquid Biopsy Market (2015-2026)
Figure 3.44: Trends and Forecast for Non-Cancer in the Global Liquid Biopsy Market (2015-2026)
Figure 3.45: Trends of the Global Liquid Biopsy Market ($M) by Clinical Application (2015-2020)
Figure 3.46: Forecast for the Global Liquid Biopsy Market ($M) by Clinical Application (2021-2026)
Figure 3.47: Trends and Forecast for Early Cancer Screening in the Global Liquid Biopsy Market (2015-2026)
Figure 3.48: Trends and Forecast for Therapy Selection in the Global Liquid Biopsy Market (2015-2026)
Figure 3.49: Trends and Forecast for Treatment Monitoring in the Global Liquid Biopsy Market (2015-2026)
Figure 3.50: Trends and Forecast for Recurrence Monitoring in the Global Liquid Biopsy Market (2015-2026)
Figure 3.51: Trends of the Global Liquid Biopsy Market ($M) by End User (2015-2020)
Figure 3.52: Forecast for the Global Liquid Biopsy Market ($M) by End User (2021-2026)
Figure 3.53: Trends and Forecast for Reference Laboratories in the Global Liquid Biopsy Market (2015-2026)
Figure 3.54: Trends and Forecast for Hospitals and Physician Laboratories in the Global Liquid Biopsy Market (2015-2026)
Figure 3.55: Trends and Forecast for Academic and Research Centers in the Global Liquid Biopsy Market (2015-2026)
Figure 3.56: Trends and Forecast for Other End Users in the Global Liquid Biopsy Market (2015-2026)

Chapter 4. Market Trends and Forecast Analysis from 2015 to 2026
Figure 4.1: Trends of the Global Liquid Biopsy Market ($M) by Region (2015-2020)
Figure 4.2: Forecast for the Global Liquid Biopsy Market ($M) by Region (2021-2026)
Figure 4.3: Trends and Forecast for the North American Liquid Biopsy Market (2015-2026)
Figure 4.4: Trends of the North American Liquid Biopsy Market ($M) by Product (2015-2020)
Figure 4.5: Forecast for the North American Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 4.6: Trends of the North American Liquid Biopsy Market ($M) by Circulating Biomarker (2015-2020)
Figure 4.7: Forecast for the North American Liquid Biopsy Market ($M) by Circulating Biomarker (2021-2026)
Figure 4.8: Trends of the North American Liquid Biopsy Market ($M) by Application (2015-2020)
Figure 4.9: Forecast for the North American Liquid Biopsy Market ($M) by Application (2021-2026)
Figure 4.10: Trends of the North American Liquid Biopsy Market ($M) by Clinical Application (2015-2020)
Figure 4.11: Forecast for the North American Liquid Biopsy Market ($M) by Clinical Application (2021-2026)
Figure 4.12: Trends of the North American Liquid Biopsy Market ($M) by End User (2015-2020)
Figure 4.13: Forecast for the North American Liquid Biopsy Market ($M) by End User (2021-2026)
Figure 4.14: Trends and Forecast for the United States Liquid Biopsy Market (2015-2026)
Figure 4.15: Trends and Forecast for the Canadian Liquid Biopsy Market (2015-2026)
Figure 4.16: Trends and Forecast for the Mexican Liquid Biopsy Market (2015-2026)
Figure 4.17: Trends and Forecast for the European Liquid Biopsy Market (2015-2026)
Figure 4.18: Trends of the European Liquid Biopsy Market ($M) by Product (2015-2020)
Figure 4.19: Forecast for the European Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 4.20: Trends of the European Liquid Biopsy Market ($M) by Circulating Biomarker (2015-2020)
Figure 4.21: Forecast for the European Liquid Biopsy Market ($M) by Circulating Biomarker (2021-2026)
Figure 4.22: Trends of the European Liquid Biopsy Market ($M) by Application (2015-2020)
Figure 4.23: Forecast for the European Liquid Biopsy Market ($M) by Application (2021-2026)
Figure 4.24: Trends of the European Liquid Biopsy Market ($M) by Clinical Application (2015-2020)
Figure 4.25: Forecast for the European Liquid Biopsy Market ($M) by Clinical Application (2021-2026)
Figure 4.26: Trends of the European Liquid Biopsy Market ($M) by End User (2015-2020)
Figure 4.27: Forecast for the European Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 4.28: Trends and Forecast for the United Kingdom Liquid Biopsy Market (2015-2026)
Figure 4.29: Trends and Forecast for the German Liquid Biopsy Market (2015-2026)
Figure 4.30: Trends and Forecast for the French Liquid Biopsy Market (2015-2026)
Figure 4.31: Trends and Forecast for the Italian Liquid Biopsy Market (2015-2026)
Figure 4.32: Trends and Forecast for the Spanish Liquid Biopsy Market (2015-2026)
Figure 4.33: Trends and Forecast for the APAC Liquid Biopsy Market (2015-2026)
Figure 4.34: Trends of the APAC Liquid Biopsy Market ($M) by Product (2015-2020)
Figure 4.35: Forecast for the APAC Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 4.36: Trends of the APAC Liquid Biopsy Market ($M) by Circulating Biomarker (2015-2020)
Figure 4.37: Forecast for the APAC Liquid Biopsy Market ($M) by Circulating Biomarker (2021-2026)
Figure 4.38: Trends of the APAC Liquid Biopsy Market ($M) by Application (2015-2020)
Figure 4.39: Forecast for the APAC Liquid Biopsy Market ($M) by Application (2021-2026)
Figure 4.40: Trends of the APAC Liquid Biopsy Market ($M) by Clinical Application (2015-2020)
Figure 4.41: Forecast for the APAC Liquid Biopsy Market ($M) by Clinical Application (2021-2026)
Figure 4.42: Trends of the APAC Liquid Biopsy Market ($M) by End User (2015-2020)
Figure 4.43: Forecast for the APAC Liquid Biopsy Market ($M) by End User (2021-2026)
Figure 4.44: Trends and Forecast for the Japanese Liquid Biopsy Market (2015-2026)
Figure 4.45: Trends and Forecast for the Chinese Liquid Biopsy Market (2015-2026)
Figure 4.46: Trends and Forecast for the Indian Liquid Biopsy Market (2015-2026)
Figure 4.47: Trends and Forecast for the ROW Liquid Biopsy Market (2015-2026)
Figure 4.48: Trends of the ROW Liquid Biopsy Market ($M) by Product (2015-2020)
Figure 4.49: Forecast for the ROW Liquid Biopsy Market ($M) by Product (2021-2026)
Figure 4.50: Trends of the ROW Liquid Biopsy Market ($M) by Circulating Biomarker (2015-2020)
Figure 4.51: Forecast for the ROW Liquid Biopsy Market ($M) by Circulating Biomarker (2021-2026)
Figure 4.52: Trends of the ROW Liquid Biopsy Market ($M) by Application (2015-2020)
Figure 4.53: Forecast for the ROW Liquid Biopsy Market ($M) by Application (2021-2026)
Figure 4.54: Trends of the ROW Liquid Biopsy Market ($M) by Clinical Application (2015-2020)
Figure 4.55: Forecast for the ROW Liquid Biopsy Market ($M) by Clinical Application (2021-2026)
Figure 4.56: Trends of the ROW Liquid Biopsy Market ($M) by End User (2015-2020)
Figure 4.57: Forecast for the ROW Liquid Biopsy Market ($M) by End User (2021-2026)
Figure 4.58: Trends and Forecast for the Brazilian Liquid Biopsy Market (2015-2026)

Chapter 5. Competitor Analysis
Figure 5.1: Market Share Analysis of the Global Liquid Biopsy Market in 2020
Figure 5.2: Global Liquid Biopsy Market: Top Five Players’ Market Share Analysis in 2020
Figure 5.3: Headquarters of Competitors in the Global Liquid Biopsy Market
Figure 5.4: Porter’s Five Forces Analysis of the Global Liquid Biopsy Market

Chapter 6. Growth Opportunities and Strategic Analysis
Figure 6.1: Growth Opportunities for the Global Liquid Biopsy Market by Product
Figure 6.2: Growth Opportunities for the Global Liquid Biopsy Market by Circulating Biomarker
Figure 6.3: Growth Opportunities for the Global Liquid Biopsy Market by Application
Figure 6.4: Growth Opportunities for the Global Liquid Biopsy Market by Clinical Application
Figure 6.5: Growth Opportunities for the Global Liquid Biopsy Market by End User
Figure 6.6: Growth Opportunities for the Global Liquid Biopsy Market by Region
Figure 6.7: Emerging Trends in the Global Liquid Biopsy Market
Figure 6.8: Strategic Initiatives by Major Competitors in the Global Liquid Biopsy Market

Chapter 7. Company Profiles of Leading Players
Figure 7.1: Headquarter Location of Bio-Rad Laboratories
Figure 7.2: Headquarter Location of QIAGEN
Figure 7.3: Headquarter Location of MDxHealth
Figure 7.4: Major Liquid Biopsy Locations of Myriad Genetics
Figure 7.5: Headquarter Location of Biocept, Inc.
Figure 7.6: Major Liquid Biopsy Locations of Carlisle F. Hoffmann-La Roche Ltd.
Figure 7.7: Headquarter Location of Thermo Fisher Scientific Inc.
Figure 7.8: Major Manufacturing Locations of Illumina, Inc.
Figure 7.9: Headquarter Location of Cardiff Oncology
Figure 7.10: Major Liquid Biopsy Locations of Guardant Health

List of Tables
Chapter 1. Executive Summary
Table 1.1: Global Liquid Biopsy Market Parameters and Attributes

Chapter 3. Market Trends and Forecast Analysis from 2015 to 2026
Table 3.1: Trends of the Global Liquid Biopsy Market (2015-2020)
Table 3.2: Forecast for the Global Liquid Biopsy Market (2021-2026)
Table 3.3: Market Size and CAGR of Various Products in the Global Liquid Biopsy Market (2015-2020)
Table 3.4: Market Size and CAGR of Various Products in the Global Liquid Biopsy Market (2021-2026)
Table 3.5: Trends of Assay Kits in the Global Liquid Biopsy Market (2015-2020)
Table 3.6: Forecast for Assay Kits in the Global Liquid Biopsy Market (2021-2026)
Table 3.7: Trends of Instruments in the Global Liquid Biopsy Market (2015-2020)
Table 3.8: Forecast for Instruments in the Global Liquid Biopsy Market (2021-2026)
Table 3.9: Trends of Services in the Global Liquid Biopsy Market (2015-2020)
Table 3.10: Forecast for Services in the Global Liquid Biopsy Market (2021-2026)
Table 3.11: Market Size and CAGR of Various Circulating Biomarkers in the Global Liquid Biopsy Market (2015-2020)
Table 3.12: Market Size and CAGR of Various Circulating Biomarkers in the Global Liquid Biopsy Market (2021-2026)
Table 3.13: Trends of Circulating Tumor Cells (CTCs) in the Global Liquid Biopsy Market (2015-2020)
Table 3.14: Forecast for Circulating Tumor Cells (CTCs) in the Global Liquid Biopsy Market (2021-2026)
Table 3.15: Trends of Circulating Tumor DNA (ctDNA) in the Global Liquid Biopsy Market (2015-2020)
Table 3.16: Forecast for Circulating Tumor DNA (ctDNA) in the Global Liquid Biopsy Market (2021-2026)
Table 3.17: Trends of Cell-Free DNA (cfDNA) in the Global Liquid Biopsy Market (2015-2020)
Table 3.18: Forecast for Cell-Free DNA (cfDNA) in the Global Liquid Biopsy Market (2021-2026)
Table 3.19: Trends of Extracellular Vesicles (EVs) in the Global Liquid Biopsy Market (2015-2020)
Table 3.20: Forecast for Extracellular Vesicles (EVs) in the Global Liquid Biopsy Market (2021-2026)
Table 3.21: Trends of Other Circulating Biomarkers in the Global Liquid Biopsy Market (2015-2020)
Table 3.22: Forecast for Other Circulating Biomarkers in the Global Liquid Biopsy Market (2021-2026)
Table 3.23: Market Size and CAGR of Various Applications in the Global Liquid Biopsy Market (2015-2020)
Table 3.24: Market Size and CAGR of Various Applications in the Global Liquid Biopsy Market (2021-2026)
Table 3.25: Trends of Oncology in the Global Liquid Biopsy Market (2015-2020)
Table 3.26: Forecast for Oncology in the Global Liquid Biopsy Market (2021-2026)
Table 3.27: Market Size and CAGR of Various Oncology Types in the Global Liquid Biopsy Market by Value (2015-2020)
Table 3.28: Market Size and CAGR of Various Oncology Types in the Global Liquid Biopsy Market by Value (2021-2026)
Table 3.29: Trends of Lung Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.30: Forecast for Lung Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.31: Trends of Breast Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.32: Forecast for Breast Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.33: Trends of Colorectal Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.34: Forecast for Colorectal Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.35: Trends of Prostate Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.36: Forecast for Prostate Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.37: Trends of Liver Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.38: Forecast for Liver Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.39: Trends of Other Cancers in the Global Liquid Biopsy Market (2015-2020)
Table 3.40: Forecast for Other Cancers in the Global Liquid Biopsy Market (2021-2026)
Table 3.41: Trends of Non-Cancer in the Global Liquid Biopsy Market (2015-2020)
Table 3.42: Forecast for Non-Cancer in the Global Liquid Biopsy Market (2021-2026)
Table 3.43: Market Size and CAGR of Various Clinical Applications in the Global Liquid Biopsy Market (2015-2020)
Table 3.44: Market Size and CAGR of Various Clinical Applications in the Global Liquid Biopsy Market (2021-2026)
Table 3.45: Trends of Early Cancer Screening in the Global Liquid Biopsy Market (2015-2020)
Table 3.46: Forecast for Early Cancer Screening in the Global Liquid Biopsy Market (2021-2026)
Table 3.47: Trends of Therapy Selection in the Global Liquid Biopsy Market (2015-2020)
Table 3.48: Forecast for Therapy Selection in the Global Liquid Biopsy Market (2021-2026)
Table 3.49: Trends of Treatment Monitoring in the Global Liquid Biopsy Market (2015-2020)
Table 3.50: Forecast for Treatment Monitoring in the Global Liquid Biopsy Market (2021-2026)
Table 3.51: Trends of Recurrence Monitoring in the Global Liquid Biopsy Market (2015-2020)
Table 3.52: Forecast for Recurrence Monitoring in the Global Liquid Biopsy Market (2021-2026)
Table 3.53: Market Size and CAGR of Various End Users in the Global Liquid Biopsy Market (2015-2020)
Table 3.54: Market Size and CAGR of Various End Users in the Global Liquid Biopsy Market (2021-2026)
Table 3.55: Trends of Reference Laboratories in the Global Liquid Biopsy Market (2015-2020)
Table 3.56: Forecast for Reference Laboratories in the Global Liquid Biopsy Market (2021-2026)
Table 3.57: Trends of Hospitals and Physician Laboratories in the Global Liquid Biopsy Market (2015-2020)
Table 3.58: Forecast for Hospitals and Physician Laboratories in the Global Liquid Biopsy Market (2021-2026)
Table 3.59: Trends of Academic and Research Centers in the Global Liquid Biopsy Market (2015-2020)
Table 3.60: Forecast for Academic and Research Centers in the Global Liquid Biopsy Market (2021-2026)
Table 3.61: Trends of Other End Users in the Global Liquid Biopsy Market (2015-2020)
Table 3.62: Forecast for Other End Users in the Global Liquid Biopsy Market (2021-2026)

Chapter 4. Market Trends and Forecast Analysis from 2015 to 2026
Table 4.1: Market Size and CAGR of Various Regions in the Global Liquid Biopsy Market by Value (2015-2020)
Table 4.2: Market Size and CAGR of Various Regions in the Global Liquid Biopsy Market by Value (2021-2026)
Table 4.3: Trends of the North American Liquid Biopsy Market (2015-2020)
Table 4.4: Forecast for the North American Liquid Biopsy Market (2021-2026)
Table 4.5: Market Size and CAGR of Various Products in the North American Liquid Biopsy Market by Value (2015-2020)
Table 4.6: Market Size and CAGR of Various Products in the North American Liquid Biopsy Market by Value (2021-2026)
Table 4.7: Market Size and CAGR of Circulating Biomarkers in the North American Liquid Biopsy Market by Value (2015-2020)
Table 4.8: Market Size and CAGR of Circulating Biomarkers in the North American Liquid Biopsy Market by Value (2021-2026)
Table 4.9: Market Size and CAGR of Various Applications in the North American Liquid Biopsy Market by Value (2015-2020)
Table 4.10: Market Size and CAGR of Various Applications in the North American Liquid Biopsy Market by Value (2021-2026)
Table 4.11: Market Size and CAGR of Various Clinical Applications in the North American Liquid Biopsy Market by Value (2015-2020)
Table 4.12: Market Size and CAGR of Various Clinical Applications in the North American Liquid Biopsy Market by Value (2021-2026)
Table 4.13: Market Size and CAGR of Various End Users in the North American Liquid Biopsy Market by Value (2015-2020)
Table 4.14: Market Size and CAGR of Various End Users in the North American Liquid Biopsy Market by Value (2021-2026)
Table 4.15: Trends and Forecast for the United States Liquid Biopsy Market (2015-2026)
Table 4.16: Trends and Forecast for the Canadian Liquid Biopsy Market (2015-2026)
Table 4.17: Trends and Forecast for the Mexican Liquid Biopsy Market (2015-2026)
Table 4.18: Trends of the European Liquid Biopsy Market (2015-2020)
Table 4.19: Forecast for the European Liquid Biopsy Market (2021-2026)
Table 4.20: Market Size and CAGR of Various Products in the European Liquid Biopsy Market by Value (2015-2020)
Table 4.21: Market Size and CAGR of Various Products in the European Liquid Biopsy Market by Value (2021-2026)
Table 4.22: Market Size and CAGR of Various Circulating Biomarkers in the European Liquid Biopsy Market by Value (2015-2020)
Table 4.23: Market Size and CAGR of Various Circulating Biomarkers in the European Liquid Biopsy Market by Value (2021-2026)
Table 4.24: Market Size and CAGR of Various Applications in the European Liquid Biopsy Market by Value (2015-2020)
Table 4.25: Market Size and CAGR of Various Applications in the European Liquid Biopsy Market by Value (2021-2026)
Table 4.26: Market Size and CAGR of Various Clinical Applications in the European Liquid Biopsy Market by Value (2015-2020)
Table 4.27: Market Size and CAGR of Various Clinical Applications in the European Liquid Biopsy Market by Value (2021-2026)
Table 4.28: Market Size and CAGR of Various End Users in the European Liquid Biopsy Market by Value (2015-2020)
Table 4.29: Market Size and CAGR of Various End Users in the European Liquid Biopsy Market by Value (2021-2026)
Table 4.30: Trends and Forecast for the United Kingdom Liquid Biopsy Market (2015-2026)
Table 4.31: Trends and Forecast for the German Liquid Biopsy Market (2015-2026)
Table 4.32: Trends and Forecast for the French Liquid Biopsy Market (2015-2026)
Table 4.33: Trends and Forecast for the Italian Liquid Biopsy Market (2015-2026)
Table 4.34: Trends and Forecast for the Spanish Liquid Biopsy Market (2015-2026)
Table 4.35: Trends of the APAC Liquid Biopsy Market (2015-2020)
Table 4.36: Forecast for the APAC Liquid Biopsy Market (2021-2026)
Table 4.37: Market Size and CAGR of Various Products in the APAC Liquid Biopsy Market by Value (2015-2020)
Table 4.38: Market Size and CAGR of Various Products in the APAC Liquid Biopsy Market by Value (2021-2026)
Table 4.39: Market Size and CAGR of Various Circulating Biomarkers in the APAC Liquid Biopsy Market by Value (2015-2020)
Table 4.40: Market Size and CAGR of Various Circulating Biomarkers in the APAC Liquid Biopsy Market by Value (2021-2026)
Table 4.41: Market Size and CAGR of Various Applications in the APAC Liquid Biopsy Market by Value (2015-2020)
Table 4.42: Market Size and CAGR of Various Applications in the APAC Liquid Biopsy Market by Value (2021-2026)
Table 4.43: Market Size and CAGR of Various Clinical Applications in the APAC Liquid Biopsy Market by Value (2015-2020)
Table 4.44: Market Size and CAGR of Various Clinical Applications in the APAC Liquid Biopsy Market by Value (2021-2026)
Table 4.45: Market Size and CAGR of Various End Users in the APAC Liquid Biopsy Market by Value (2015-2020)
Table 4.46: Market Size and CAGR of Various End Users in the APAC Liquid Biopsy Market by Value (2021-2026)
Table 4.47: Trends and Forecast for the Japanese Liquid Biopsy Market (2015-2026)
Table 4.48: Trends and Forecast for the Chinese Liquid Biopsy Market (2015-2026)
Table 4.49: Trends and Forecast for the Indian Liquid Biopsy Market (2015-2026)
Table 4.50: Trends of the ROW Liquid Biopsy Market (2015-2020)
Table 4.51: Forecast for the ROW Liquid Biopsy Market (2021-2026)
Table 4.52: Market Size and CAGR of Various Products in the ROW Liquid Biopsy Market by Value (2015-2020)
Table 4.53: Market Size and CAGR of Various Products in the ROW Liquid Biopsy Market by Value (2021-2026)
Table 4.54: Market Size and CAGR of Various Circulating Biomarkers in the ROW Liquid Biopsy Market by Value (2015-2020)
Table 4.55: Market Size and CAGR of Various Circulating Biomarkers in the ROW Liquid Biopsy Market by Value (2021-2026)
Table 4.56: Market Size and CAGR of Various Applications in the ROW Liquid Biopsy Market by Value (2015-2020)
Table 4.57: Market Size and CAGR of Various Applications in the ROW Liquid Biopsy Market by Value (2021-2026)
Table 4.58: Market Size and CAGR of Various Clinical Applications in the ROW Liquid Biopsy Market by Value (2015-2020)
Table 4.59: Market Size and CAGR of Various Clinical Applications in the ROW Liquid Biopsy Market by Value (2021-2026)
Table 4.60: Market Size and CAGR of Various End Users in the ROW Liquid Biopsy Market by Value (2015-2020)
Table 4.61: Market Size and CAGR of Various End Users in the ROW Liquid Biopsy Market by Value (2021-2026)
Table 4.62: Trends and Forecast for the Brazilian Liquid Biopsy Market (2015-2026)

Chapter 5. Competitor Analysis
Table 5.1: Product Mapping of Liquid Biopsy Suppliers Based on Clinical Application
Table 5.2: Rankings of Suppliers Based on Revenue of the Liquid Biopsy Market
Table 5.3: Operational Integration of Liquid Biopsy Suppliers

Chapter 6. Growth Opportunities and Strategic Analysis
Table 6.1: New Product Launches by Major Liquid Biopsy Producers (2015-2021) (Source: Lucintel)
Note: Product cover images may vary from those shown
  • Bio-Rad Laboratories
  • QIAGEN
  • MDxHealth
  • Myriad Genetics
  • Biocept, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Cardiff Oncology
  • Guardant Health
Note: Product cover images may vary from those shown

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...

Adroll
adroll